Intratumoral Heterogeneity, Its Contribution to Therapy Resistance and Methodological Caveats to Assessment
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Intratumoral Heterogeneity, Its Contribution to Therapy Resistance and Methodological Caveats to Assessment
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 4, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2014-06-10
DOI
10.3389/fonc.2014.00142
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A tale of two approaches: complementary mechanisms of cytotoxic and targeted therapy resistance may inform next-generation cancer treatments
- (2013) K. Masui et al. CARCINOGENESIS
- Socio-demographic factors and their impact on the number of resections for patients with recurrent glioblastoma
- (2013) Y. Sia et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Parallel evolution of tumour subclones mimics diversity between tumours
- (2013) Pierre Martinez et al. JOURNAL OF PATHOLOGY
- Somatic alterations as the basis for resistance to targeted therapies
- (2013) Brian G Blair et al. JOURNAL OF PATHOLOGY
- Tumour heterogeneity and cancer cell plasticity
- (2013) Corbin E. Meacham et al. NATURE
- The causes and consequences of genetic heterogeneity in cancer evolution
- (2013) Rebecca A. Burrell et al. NATURE
- Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics
- (2013) A. Sottoriva et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer Genome Landscapes
- (2013) B. Vogelstein et al. SCIENCE
- Clonal competition with alternating dominance in multiple myeloma
- (2012) J. J. Keats et al. BLOOD
- Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty
- (2012) Jeffrey A. Magee et al. CANCER CELL
- A Missing Link in Genotype-Directed Cancer Therapy
- (2012) René Bernards CELL
- Resistance to BRAF Inhibition in BRAF-Mutant Colon Cancer Can Be Overcome with PI3K Inhibition or Demethylating Agents
- (2012) M. Mao et al. CLINICAL CANCER RESEARCH
- Genome sequencing and cancer
- (2012) Elaine R Mardis CURRENT OPINION IN GENETICS & DEVELOPMENT
- Complexity in the signaling network: insights from the use of targeted inhibitors in cancer therapy
- (2012) J. S. Logue et al. GENES & DEVELOPMENT
- Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR
- (2012) Anirudh Prahallad et al. NATURE
- Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
- (2012) Li Ding et al. NATURE
- Absolute quantification of somatic DNA alterations in human cancer
- (2012) Scott L Carter et al. NATURE BIOTECHNOLOGY
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intratumor Heterogeneity: Seeing the Wood for the Trees
- (2012) T. A. Yap et al. Science Translational Medicine
- Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development
- (2011) Philip J. Stephens et al. CELL
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Insight into the heterogeneity of breast cancer through next-generation sequencing
- (2011) Hege G. Russnes et al. JOURNAL OF CLINICAL INVESTIGATION
- The proliferation rate paradox in antimitotic chemotherapy
- (2011) Timothy J. Mitchison MOLECULAR BIOLOGY OF THE CELL
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Hierarchy of Self-Renewing Tumor-Initiating Cell Types in Glioblastoma
- (2010) Ruihuan Chen et al. CANCER CELL
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
- (2010) Roel G.W. Verhaak et al. CANCER CELL
- Cancer stem cells: a new framework for the design of tumor therapies
- (2010) Boyan K. Garvalov et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Evolution of an adenocarcinoma in response to selection by targeted kinase inhibitors
- (2010) Steven JM Jones et al. GENOME BIOLOGY
- The cancer genome
- (2009) Michael R. Stratton et al. NATURE
- DNA Damage Responses: Mechanisms and Roles in Human Disease: 2007 G.H.A. Clowes Memorial Award Lecture
- (2008) M. B. Kastan MOLECULAR CANCER RESEARCH
- Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers
- (2008) Wataru Sakai et al. NATURE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started